Growth hormone axis
GHRP-6
Also called SKF-110679
per administration
It has been used in people, but no trial has settled how much or how often.
Quick start
GHRP-6 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–200 mcg per administration
- How often
- Twice a day
- Where
- Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
- Time to steady level
- ~2 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Key properties
Molecular reference data.
- Formula
- C46H56N12O6
- Mol. weight
- 873 Da
- CAS
- 87616-84-0
- PubChem CID
- 4345065
External references
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for GHRP-6 describe 100–200 mcg per administration. Descriptive only, not a recommendation.
Roughly 15–20 minutes in plasma.
An early growth-hormone-releasing hexapeptide given to human volunteers, but no trial fixes a subcutaneous amount or schedule; the circulating figures are community-derived, so no schedule table is shown.
Modelled level — twice a day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 14/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- GHRP-6 (SKF-110679) secretagogue literatureOne of the first growth-hormone-releasing peptides taken into human study; injected amounts in circulation are community-derived, not trial-established.